Genetics Experts

Kevin Whaley

Mapp Biopharmaceutical Inc
United States of America

Kevin Whaley


Kevin Whaley has worked for the last 30 years on the development of multipurpose prevention technologies (MPTs), i.e. products that simultaneously prevent sexually transmitted diseases and unwanted pregnancy. He co-founded Mapp to develop antibody-based MPTs, therapeutics and mucosal vaccines that are appropriate for large, cost-sensitive, global health markets.   

Research Interest


Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences
  • Cell & Tissue Science

    November 15-17, 2018 Berlin, Germany

  • Cell & Stem Cell Research

    November 15-17, 2018 Berlin, Germany

View more
Relevant Topics